Cargando…
Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006
Antimicrobial drug resistance can hinder gonorrhea prevention and control efforts. In this study, we analyzed historical ciprofloxacin resistance data and gonorrhea incidence data to examine the possible effect of antimicrobial drug resistance on gonorrhea incidence at the population level. We analy...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966369/ https://www.ncbi.nlm.nih.gov/pubmed/24655615 http://dx.doi.org/10.3201/eid2004.131288 |
_version_ | 1782308900476813312 |
---|---|
author | Chesson, Harrell W. Kirkcaldy, Robert D. Gift, Thomas L. Owusu-Edusei, Kwame Weinstock, Hillard S. |
author_facet | Chesson, Harrell W. Kirkcaldy, Robert D. Gift, Thomas L. Owusu-Edusei, Kwame Weinstock, Hillard S. |
author_sort | Chesson, Harrell W. |
collection | PubMed |
description | Antimicrobial drug resistance can hinder gonorrhea prevention and control efforts. In this study, we analyzed historical ciprofloxacin resistance data and gonorrhea incidence data to examine the possible effect of antimicrobial drug resistance on gonorrhea incidence at the population level. We analyzed data from the Gonococcal Isolate Surveillance Project and city-level gonorrhea incidence rates from surveillance data for 17 cities during 1991–2006. We found a strong positive association between ciprofloxacin resistance and gonorrhea incidence rates at the city level during this period. Their association was consistent with predictions of mathematical models in which resistance to treatment can increase gonorrhea incidence rates through factors such as increased duration of infection. These findings highlight the possibility of future increases in gonorrhea incidence caused by emerging cephalosporin resistance. |
format | Online Article Text |
id | pubmed-3966369 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-39663692014-04-02 Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006 Chesson, Harrell W. Kirkcaldy, Robert D. Gift, Thomas L. Owusu-Edusei, Kwame Weinstock, Hillard S. Emerg Infect Dis Research Antimicrobial drug resistance can hinder gonorrhea prevention and control efforts. In this study, we analyzed historical ciprofloxacin resistance data and gonorrhea incidence data to examine the possible effect of antimicrobial drug resistance on gonorrhea incidence at the population level. We analyzed data from the Gonococcal Isolate Surveillance Project and city-level gonorrhea incidence rates from surveillance data for 17 cities during 1991–2006. We found a strong positive association between ciprofloxacin resistance and gonorrhea incidence rates at the city level during this period. Their association was consistent with predictions of mathematical models in which resistance to treatment can increase gonorrhea incidence rates through factors such as increased duration of infection. These findings highlight the possibility of future increases in gonorrhea incidence caused by emerging cephalosporin resistance. Centers for Disease Control and Prevention 2014-04 /pmc/articles/PMC3966369/ /pubmed/24655615 http://dx.doi.org/10.3201/eid2004.131288 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Chesson, Harrell W. Kirkcaldy, Robert D. Gift, Thomas L. Owusu-Edusei, Kwame Weinstock, Hillard S. Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006 |
title | Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006 |
title_full | Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006 |
title_fullStr | Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006 |
title_full_unstemmed | Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006 |
title_short | Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006 |
title_sort | ciprofloxacin resistance and gonorrhea incidence rates in 17 cities, united states, 1991–2006 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966369/ https://www.ncbi.nlm.nih.gov/pubmed/24655615 http://dx.doi.org/10.3201/eid2004.131288 |
work_keys_str_mv | AT chessonharrellw ciprofloxacinresistanceandgonorrheaincidenceratesin17citiesunitedstates19912006 AT kirkcaldyrobertd ciprofloxacinresistanceandgonorrheaincidenceratesin17citiesunitedstates19912006 AT giftthomasl ciprofloxacinresistanceandgonorrheaincidenceratesin17citiesunitedstates19912006 AT owusueduseikwame ciprofloxacinresistanceandgonorrheaincidenceratesin17citiesunitedstates19912006 AT weinstockhillards ciprofloxacinresistanceandgonorrheaincidenceratesin17citiesunitedstates19912006 |